ARTICLE

FindCenter AddIcon

The Movement to Decriminalize Psilocybin, Explained

By Dustin Marlan — 2021

The latest frontier in state and local drug reform has been the loosening of legal restrictions on psilocybin—the psychoactive compound in “magic mushrooms.”

Read on theappeal.org

FindCenter Post-Image

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

Article
Zoe Jahn, Monnica T. Williams
2019
FindCenter AddIcon
FindCenter Post-Image

Who Owns the Land?

No one disputes that decades ago local Indians were unfairly deprived of hundreds of thousands of acres that were guaranteed to them in perpetuity by solemn treaty; yet no one can agree about what should be done to correct that injustice today.

Article
Louise Erdrich and Michael Dorris
1988
FindCenter AddIcon
FindCenter Post-Image

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

Article
Carolyn Gregoire
2015
FindCenter AddIcon
FindCenter Post-Image

Why Canada Could Be Next to Allow Psychedelic Therapy (And How It’s Already Changing Lives)

Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.

Article
Amanda Siebert
2020
FindCenter AddIcon
FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

Article
Benjamin Hearn
2020
FindCenter AddIcon
FindCenter Post-Image

Crash Course in the Nature of Mind

Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.

Article
Julie Scharper
FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

Article
Johann Hari
2018
FindCenter AddIcon
FindCenter Post-Image

‘60 Minutes’ Segment Explores Psychedelics Research at Johns Hopkins

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

Article
60 Minutes
2019
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths, Ph.D.

We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.

Article
David Jay Brown with Louise Reitman
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon

EXPLORE TOPIC

Drug Policy